Every day, you rely on data to more effectively manage disease. But, manually integrating these separate findings can be ineffective and often time consuming. In fact, it can often feel like the data is managing you—rather than the other way around. With the ZEISS Integrated Diagnostic Imaging platform, you can now individualize treatment to your patients’ specific needs, enhancing your treatment capabilities and expanding your level of care.
Multi-modality in diagnostics and imaging are increasingly becoming the standard of care in eye clinics. The ability to assess and compare the data from different modalities provides clinicians a new level of confidence for proposing a treatment regimen that is customized to each patient's individual needs. In this video, Dr. Giovanni Staurenghi explains the need for multi-modal diagnostics today. The question is... are today's multi-modality imaging practices effective and efficient?
For the latest posts and images from ZEISS medical technology, follow us on social:
As a clinician, your patient is your first priority, and that means providing the best level of care available today. However, that’s not all that is needed. The burgeoning patient population also demands efficiency from doctors and practices, and while the advent of new and better technologies have elevated care for patients, clinicians no longer have the time to log onto multiple platforms to review different sets of data.
“I need to be able to use this mountain of diagnostic data to support complex and often expensive treatment decisions,” says Dr. Peter Karth, MD, MBA. And he needs to be able to do this quickly.
Enter the Integrated Diagnostic Imaging platform from ZEISS, the software-driven multi-modality solution that gathers, combines and associates data from different diagnostics devices, improving decision making and efficiency.
True Color ultra-widefield fundus imaging and OCT Angiography have played a crucial role in the diagnosis and management of retinal diseases—elevating the level of care clinicians provide their patients. Now learn how the integrated diagnostics imaging platform from ZEISS takes this a step further.
Glaucoma is a complex progressive disease that requires continuous follow-up assessment. The gold standard in glaucoma care has been visual field testing, while optical coherence tomography has shown to play a significant role in enabling clinicians to identify changes in progression that could impact disease management. When data from the two exams are combined and associated, the results can be eye-opening. Take a look.
In this article, Dr. Peter Karth provides a detailed overview of the data dilemma facing clinicians today and how an integrated approach to multi-modality diagnostics, pioneered by ZEISS, is paving the way for the future. Share your interest in integrated diagnostic imaging with us, and immediately you'll be provided the download.